Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
neuroloop
Freiburg, Baden-Württemberg, Germanyneuroloop.de ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
neuroloop has developed a novel implantable closed-loop neuromodulation device/platform targeting the vagus nerve for chronic disease management. The company collaborates with Merck KGaA and B. Braun SE to develop bioelectronic devices for targeted treatment of chronic inflammatory diseases. Initial preclinical data were expected by late 2022; further clinical development status not publicly disclosed as of June 2025.
- Therapeutic areas
- CardiovascularImmunologyNeurology
- Modalities
- DeviceBioelectronic deviceNeuromodulation technology
- Industry
- Implantable Medical Devices
02
Partnerships
Merck KGaA/Darmstadt/GermanyB. Braun SE/Aesculap AG
Beyond the preview
Go deeper on neuroloop.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on neuroloop.